Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer

INTRODUCTION: Treatments for young patients with gastric cancer (GC) remain poorly defined, and their effects on survival are uncertain. We aimed to investigate the receipt of chemotherapy by age category (18–49, 50–64, and 65–85 years) and explore whether age differences in chemotherapy matched sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuming, Xie, Jingjing, Huang, Weicai, Chen, Hao, Xi, Sujuan, Li, Tuanjie, Chen, Chuanli, Sun, Zepang, Hu, Yanfeng, Liu, Wei, Yu, Jiang, Zhou, Zhiwei, Cai, Shirong, Li, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556366/
https://www.ncbi.nlm.nih.gov/pubmed/33108125
http://dx.doi.org/10.14309/ctg.0000000000000253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556366/
https://www.ncbi.nlm.nih.gov/pubmed/33108125
http://dx.doi.org/10.14309/ctg.0000000000000253

Ejemplares similares